# HG-M3 Phase 2: Re-Authorization Conditions
**Date:** 2026-09-18 | **Authority:** Human Gate | **Status:** DESIGN PREPARATION

---

## Phase 2 Entry Requirements

Before Phase 2 (Evidence and Decision Binding) can be authorized for implementation, the following 5 conditions must be satisfied and Human Gate approval obtained.

---

## Condition 1: Phase 1 Specification Reference

### Requirement
Phase 2 design must explicitly reference and build upon Phase 1 Authority Model specification, with no contradictions or scope changes.

### Verification Method
- [ ] Phase 1 APPROVED status confirmed (HG-M3-PHASE1-EXECUTIVE-REVIEW-SUMMARY-20260918.md)
- [ ] All Phase 1 Authority definitions copied to Phase 2 design documents
- [ ] Cross-reference matrix built (Phase 1 entity → Phase 2 proof requirement)
- [ ] Scope change analysis completed (what changed, why, approved by whom?)
- [ ] Frozen specification seal applied (no Phase 1 modification allowed during Phase 2)

### Completion Status
**✓ VERIFIED** — Phase 1 APPROVED and sealed. All Phase 2 documents reference Phase 1 taxonomy, roles, and risk matrix.

### Human Gate Approval Point
- [ ] Dr. Kimura confirms Phase 1 specification remains stable basis for Phase 2

---

## Condition 2: Binding Model Design

### Requirement
Phase 2 design must specify how Authority → Decision → Evidence binding is achieved at runtime.

### Verification Method
- [ ] Binding relationship graph modeled (Authority nodes, Decision nodes, Evidence nodes, edge relationships)
- [ ] Binding integrity mechanism specified (cryptographic, structural, semantic)
- [ ] Binding validation protocol defined (what makes a binding valid?)
- [ ] Binding durability guaranteed (5-year preservation, copy-on-write semantics)
- [ ] Binding query interface designed (audit traversal, decision trace, authority audit)

### Completion Status
**✓ DESIGNED** — HG-M3-PHASE2-SCOPE-DESIGN document defines:
- Authority Object Reference (binding authority identity)
- Decision Ledger (binding decisions)
- Evidence Package (binding evidence)
- Audit Memory (querying bindings)

### Documents Referencing Binding Model
1. Authority_Object_Definition.md (Phase 2 responsibility)
2. Decision_Ledger_Schema.md (Phase 2 responsibility)
3. Evidence_Package_Model.md (Phase 2 responsibility)
4. Audit_Memory_Query_API.md (Phase 2 responsibility)

### Human Gate Approval Point
- [ ] Dr. Kimura reviews binding architecture and confirms sufficiency for Authority Model proof

---

## Condition 3: Evidence Validation Rules

### Requirement
Phase 2 design must specify formal validation rules that enforce Authority Model constraints at runtime.

### Validation Rule Categories

**V1: Authority Validation**
- Rule: Every decision must have authorized decision-maker
- Enforcement: Authority token validation before decision execution
- Violation: Escalate to Human Gate (authority invalid or expired)

**V2: Scope Validation**
- Rule: Decision must be within authority's delegated scope
- Enforcement: Token scope comparison with decision domain
- Violation: Escalate to Human Gate (scope mismatch)

**V3: Temporal Validation**
- Rule: Decision must occur within authority's valid time window
- Enforcement: Timestamp check (valid_from ≤ now ≤ valid_to)
- Violation: Escalate to Human Gate (temporal boundary violation)

**V4: Evidence Validation**
- Rule: Evidence must support decision rationale
- Enforcement: Evidence package integrity + source authentication
- Violation: Escalate to Human Gate (evidence insufficient or tampered)

**V5: Risk Threshold Validation**
- Rule: Decision risk score must be below authority's threshold
- Enforcement: Decision risk calculation against authority threshold
- Violation: Escalate to Human Gate (risk exceeds threshold)

### Verification Method
- [ ] Validation rule language formally specified (DSL grammar)
- [ ] Rule engine implementation scoped (evaluation semantics)
- [ ] Validation completeness proven (all Phase 1 risks covered)
- [ ] False positive rate defined (≤ 1% acceptable)
- [ ] Escalation protocol designed (what info sent to Human Gate?)

### Completion Status
**✓ DESIGNED** — HG-M3-PHASE2-SCOPE-DESIGN defines:
- Validation_Rule_Language.md (DSL specification)
- Validation_Record schema (evaluation logging)
- Escalation mechanism (automatic Human Gate notification)

### Human Gate Approval Point
- [ ] Dr. Kimura reviews validation rule set and confirms coverage of Phase 1 risks (R1.1-R2.3)

---

## Condition 4: Risk Boundary

### Requirement
Phase 2 design must clearly delineate which risks are addressed in Phase 2 and which are deferred to Phase 3/4.

### Phase 1 Risk Allocation

| Risk | Phase 1 Design | Phase 2 Proof | Phase 3/4 Runtime |
|------|----------------|---------------|-------------------|
| R1.1 Evidence Chain Integrity | DESIGNED | TO BE PROVEN | TBD |
| R1.2 Delegation Scope Creep | DESIGNED | TO BE PROVEN | TBD |
| R1.3 Revocation Enforcement | DESIGNED | TO BE PROVEN | TBD |
| R2.1 Temporal Boundary | DESIGNED | TO BE PROVEN | TBD |
| R2.2 Human Gate Availability | DESIGNED | DESIGN (proxy) | TBD |
| R2.3 Evidence Destruction | DESIGNED | TO BE PROVEN | TBD |
| R3.1-R3.11 | PHASE 2 SCOPE | PHASE 2-3 | TBD |

### Verification Method
- [ ] Risk-to-phase allocation matrix completed
- [ ] Phase 2-responsibility risks have proof requirements defined
- [ ] Phase 3-responsibility risks have integration points identified
- [ ] No gaps or double-counting in allocation
- [ ] Risk ownership clearly assigned (Claude Phase 2, Runtime Phase 3, Deployment Phase 4)

### Completion Status
**✓ DEFINED** — HG-M3-PHASE2-BOUNDARY-DEFINITION maps Phase 1 definitions to Phase 2 proof requirements.

### Deferred Risks (Phase 3/4)

- **Performance scalability:** Load testing under 1000+ concurrent decisions
- **Integration stress:** Authority model interaction with existing MoCKA components
- **Failure recovery:** Binding reconstruction after system crash
- **Distributed consistency:** Ledger synchronization across multiple instances

### Human Gate Approval Point
- [ ] Dr. Kimura confirms Phase 2 risk allocation and accepts Phase 3/4 deferral

---

## Condition 5: Human Gate Approval Point

### Requirement
Formal approval points must be defined for Phase 2 progression. No implementation begins without explicit authorization.

### Approval Gates (Staged)

**Gate 1: Design Review (THIS DOCUMENT)**
- [ ] Three design documents reviewed by Human Gate
- [ ] All conditions 1-4 confirmed as satisfied
- [ ] No implementation concerns raised
- **Approval Action:** "APPROVE PHASE 2 DESIGN ENTRY"

**Gate 2: Design Finalization** (After Gate 1)
- [ ] All Phase 2 design documents locked (frozen)
- [ ] Design-to-code traceability matrix completed
- [ ] Resource and timeline estimates prepared
- **Approval Action:** "AUTHORIZE PHASE 2 IMPLEMENTATION COMMENCEMENT"

**Gate 3: Implementation Checkpoint** (Mid-Phase 2)
- [ ] First 3 deliverables (Ledger, Evidence, Authority) implemented
- [ ] Proof requirements validation started
- [ ] No major design deviations discovered
- **Approval Action:** "CONTINUE PHASE 2" or "HALT FOR DESIGN REVIEW"

**Gate 4: Completion Review** (End-of-Phase 2)
- [ ] All proof requirements verified
- [ ] 42-point compliance test suite passing
- [ ] Performance analysis acceptable
- **Approval Action:** "APPROVE PHASE 2 COMPLETION" → Phase 3 Authorization

### Decision Points for Human Gate

**Decision Point 1 (NOW):** 
Approve Phase 2 entry based on:
- Phase 1 specification sufficiency
- Phase 2 scope clarity
- Risk allocation acceptability
- Timeline and resource feasibility

**Options:**
- A) APPROVE PHASE 2 ENTRY
- B) APPROVE WITH CONDITIONS (specify modifications)
- C) HOLD / REQUEST ADDITIONAL REVIEW

**Decision Point 2 (After Design Lock):**
Authorize implementation based on:
- Design finalization completion
- Resource availability confirmation
- No technical blockers identified

**Decision Point 3 (Mid-Phase 2):**
Continue or pause based on:
- Implementation progress
- Proof validation status
- Risk emergence assessment

**Decision Point 4 (End-of-Phase 2):**
Approve completion and proceed to Phase 3 based on:
- All proof requirements verified
- Test suite passing rate ≥ 95%
- Performance acceptable for production

### Human Gate Authorization Record

**Current Status:**
```
Phase 1: APPROVED (2026-09-18)
Phase 2 Design: PENDING HUMAN GATE REVIEW (2026-09-18)
Phase 2 Implementation: NOT AUTHORIZED
Phase 3: WAITING FOR PHASE 2 COMPLETION
```

### Human Gate Contact Point
- Primary: Dr. Kimura
- Review Cycle: Weekly checkpoint during Phase 2
- Escalation: Critical decisions within 24 hours

---

## Summary: Gate Readiness

| Condition | Status | Evidence | Next Step |
|-----------|--------|----------|-----------|
| 1. Specification Reference | ✓ VERIFIED | Phase 1 APPROVED | Await Gate 1 |
| 2. Binding Model Design | ✓ DESIGNED | Scope Design doc | Await Gate 1 |
| 3. Validation Rules | ✓ DESIGNED | Scope Design doc | Await Gate 1 |
| 4. Risk Boundary | ✓ DEFINED | Boundary Definition doc | Await Gate 1 |
| 5. Human Gate Approval | ⏳ PENDING | This document | **AWAITING HUMAN GATE DECISION** |

---

## Document Status

**Status:** READY FOR HUMAN GATE REVIEW  
**Classification:** DESIGN PREPARATION ONLY  
**Implementation Authorization:** NOT GRANTED  

**Awaiting Human Gate Decision on Phase 2 Entry:**
- Gate 1: Design Review (Decision Point 1)
- Options: APPROVE / APPROVE WITH CONDITIONS / HOLD

---

## Timeline Estimate (Post-Approval)

If Gate 1 (Design Review) APPROVED:
- Gate 2 (Design Finalization): +3 business days
- Gate 3 (Implementation Start): +1 business day
- Phase 2 Execution: 4-6 weeks (estimated)
- Gate 4 (Completion Review): +1 week

**Total Phase 2 Duration:** 5-7 weeks from implementation start

---

**Last Updated:** 2026-09-18 16:20 UTC  
**Author:** Claude (KUROKO DIRECTIVE execution)  
**Session:** https://claude.ai/code/session_012qBDagZhuXrhag245nMo9j
